CCL-2 receptor (CCR2) expressing monocytes are recruited along a CCL2 gradient to the tumor periphery (77, 78) where they mature further in the TME and develop pro-tumoral functions (79, 80). The gene discussed is CCL2; the disease is neoplasm.